SCI & TECH● LOW1h ago · Oct 24, 2026, 6:03 PM
Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer
Seeking Alpha Tech · global
Early-stage results from Zymeworks show that its ADC drug exhibits anti-tumor activity in ovarian cancer patients. This indicates a potential new therapeutic avenue for treating the disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH1h agoPfizer sees strong response for pediatric pneumonia vaccine in mid-stage trialSeeking Alpha TechSCI & TECH1h agoJimmy Carter gave up part of his farm in Georgia to install 3,852 solar panels: the project came to generate 60% of his town's electricityClarínSCI & TECH1h agoKiller AI has 1 in 3 chance of wiping out humanity within decade , boffin warnsdailystar.co.uk · United KingdomSCI & TECH1h agoMass Effect Universe looked incredible says creator who claims he advised BioWareeurogamer.net · United Kingdom